
EQT · NYSE
The supplied current consensus is Buy across 25 analysts, with a mean 12-month target of $67; the current dataset provides no low or high target, so the present target cluster and full spread cannot be established. A separate Benzinga snapshot shows a $68.62 consensus across 27 analysts, with BofA Securities the most bullish named firm at $80 and TD Cowen the least bullish at $54, although those observations are dated differently from the current consensus. Stephens lowered its target to $71 from $72 while retaining Overweight, making the identified weekly revision direction negative. The substantive disagreement is valuation and forecast sensitivity: targets remain above the share price, but discount-rate and growth assumptions have weakened.